Market Overview

UnitedHealth To Buy Diplomat Pharmacy For $300M

Share:
UnitedHealth To Buy Diplomat Pharmacy For $300M

Diplomat Pharmacy (NYSE: DPLO) shares are trading lower on Monday after the company received a $4 per share acquisition offer from UnitedHealth Group's (NYSE: UNH) OptumRx.

Optum is UnitedHealth Group's pharmacy services unit and said it would buy Diplomat Pharmacy for about $303 million. Diplomat's stock closed Friday's session at $5.81 per share with a market cap at about $441 million.

"Diplomat has a long track record of providing specialty pharmacy and infusion services but has encountered operating difficulties over the last few years," Cantor Fitzgerald analyst Steven Halper wrote in a note. "...The entrance into the PBM market has not panned out as the company probably had hoped. That said, we view the acquisition as a solid move for UNH from both a strategic and financial standpoint."

Diplomat shares were trading down 31.67% at $3.97 in Monday’s pre-market session. The stock has a 52-week high of $16.53 and a 52-week low of $2.43.

Diplomat's stock has crashed twice in 2019 amid warnings the company could not continue as a going concern. Shares fell from around $13.70 to $5.87 in late February, and again from $6.20 to $3.10 in early November.

Related Links:

Synthorx To Be Acquired By Sanofi For $2.5B

ArQule To Be Acquired By Merck For $2.7B

Latest Ratings for UNH

DateFirmActionFromTo
Jan 2020MaintainsOutperform
Jan 2020MaintainsNeutral
Jan 2020ReiteratesOverweight

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OptumAnalyst Color M&A News Health Care Top Stories Analyst Ratings General Best of Benzinga

 

Related Articles (UNH + DPLO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TSCOPiper SandlerMaintains119.0
UNPBMO CapitalMaintains200.0
UNPArgus ResearchMaintains205.0
ISRGJP MorganMaintains665.0
EHTHRBC CapitalMaintains132.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com